NovoCure (NVCR) Stock Forecast: StockMap's 2-Week Call

NVCR stock forecast: StockMap's model leans Underperform on NovoCure for the two weeks after the Nov 13 close, toward NVCR trailing the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 2 of 3 two-week windows on NVCR since Sep 24; by chance, a call on the same dates was right 51% of the time.

NovoCure last closed at $11.83, +0.94% on the session.

Against the IVW growth benchmark the position is +1.85% over the forecast window.

NovoCure's market cap is $1.38B as of November 13, 2026.

Leans down ↘: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -30 (too close to call).

Where NVCR sits: sized by market cap, coloured by the day's move.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

23 daily calls for NVCR so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks NovoCure in the 22nd percentile on return on equity, where 100 is best.

NovoCure is classified under Health Care / Health Care Equipment & Supplies.

StockMap tracks NovoCure as the 54th largest of the 142 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 74 Neutral, 52 Moderate Underperform, 13 Strong Underperform and 3 Moderate Outperform.

On that composite NovoCure ranks 99th of 142 in the group, against a group median of -0.15.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 13, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

NovoCure (NVCR) — StockMap 2-week forecast & tracked accuracy